Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ovid Therapeutics (OVID) Tax Provisions (2021 - 2022)

Ovid Therapeutics' Tax Provisions history spans 2 years, with the latest figure at $50000.0 for Q1 2022.

  • For Q1 2022, Tax Provisions fell 90.01% year-over-year to $50000.0; the TTM value through Dec 2022 reached $50000.0, down 96.24%, while the annual FY2021 figure was $1.3 million, N/A changed from the prior year.
  • Tax Provisions reached $50000.0 in Q1 2022 per OVID's latest filing, up from -$349714.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $1.5 million in Q2 2021 to a low of -$349714.0 in Q4 2021.